Photo taken on May 9, 2024 shows that Yan Kaijing, chairman of Tasly Pharmaceutical Group, is addressing an industrial conference.
BEIJING, May 14 (Xinhua) -- China's TCM product developer Tasly Pharmaceutical Group Co., Ltd. issued a white paper on digital intelligence of traditional Chinese medicine (TCM) and launched a related large model at an industrial conference on May 9, 2024.
The digital intelligence of TCM is an essential path for the TCM development, representing the new quality productive forces of high-quality TCM development, said Yan Kaijing, chairman of Tasly Pharmaceutical Group.
In order to make innovations in terms of TCM digital intelligence, combining TCM theories, clinical experience and digital technologies, Tasly and China's tech giant Huawei, jointly developed a large model featuring digital intelligence of herbs.
It is learned that the large model has embedded 38 billion parameters. After massive text data pre-training, enhanced search function and compatibility of TCM scenarios, the AI-driven large model is expected to help researchers better compile and summarize TCM-related theoretical evidence.
Yan said that the company will continue to optimize the large model to build new paradigm for TCM research and development (R&D) and better serve clinical application.
(Edited by Li Shimeng with Xinhua Silk Road, lishimeng@xinhua.org)
A single purchase
